Marcum Wealth LLC Has $468,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

Marcum Wealth LLC lessened its stake in CVS Health Co. (NYSE:CVS) by 6.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,440 shares of the pharmacy operator’s stock after selling 491 shares during the quarter. Marcum Wealth LLC’s holdings in CVS Health were worth $468,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CVS. Wedmont Private Capital increased its stake in shares of CVS Health by 0.8% during the first quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock worth $1,410,000 after purchasing an additional 146 shares in the last quarter. Moody National Bank Trust Division boosted its stake in shares of CVS Health by 0.7% in the first quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock valued at $1,776,000 after purchasing an additional 150 shares during the period. Garland Capital Management Inc. boosted its holdings in CVS Health by 0.3% in the second quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock valued at $3,591,000 after purchasing an additional 160 shares during the period. Silverlake Wealth Management LLC grew its holdings in CVS Health by 1.6% during the 1st quarter. Silverlake Wealth Management LLC now owns 11,203 shares of the pharmacy operator’s stock worth $894,000 after acquiring an additional 173 shares in the last quarter. Finally, Plimoth Trust Co. LLC lifted its holdings in CVS Health by 0.4% during the 2nd quarter. Plimoth Trust Co. LLC now owns 46,637 shares of the pharmacy operator’s stock worth $2,754,000 after buying an additional 174 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on CVS shares. Evercore ISI raised their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday. Deutsche Bank Aktiengesellschaft lowered their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and increased their price target for the company from $59.00 to $85.00 in a report on Friday, October 4th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Barclays upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $63.00 to $82.00 in a report on Thursday. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $74.74.

CVS Health Stock Up 1.3 %

Shares of NYSE:CVS opened at $66.85 on Friday. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The stock has a 50-day simple moving average of $58.84 and a 200-day simple moving average of $61.20. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The stock has a market capitalization of $84.10 billion, a P/E ratio of 11.90, a PEG ratio of 0.93 and a beta of 0.54.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm’s revenue was up 2.6% compared to the same quarter last year. During the same period last year, the company posted $2.21 earnings per share. Equities analysts forecast that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 3.98%. CVS Health’s dividend payout ratio is presently 47.33%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.